UroGen Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell UroGen Pharma and other ETFs, options, and stocks.About URGN
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology.
URGN Key Statistics
Stock Snapshot
The current UroGen Pharma(URGN) stock price is $20.10, with a market capitalization of 940.86M. The stock trades at a price-to-earnings (P/E) ratio of -5.81.
During the trading session on 2026-02-14, UroGen Pharma(URGN) shares reached a daily high of $21.61 and a low of $19.95. At a current price of $20.10, the stock is +0.8% higher than the low and still -7.0% under the high.
Trading volume for UroGen Pharma(URGN) stock has reached 785.62K, versus its average volume of 632.85K.
The stock's 52-week range extends from a low of $3.42 to a high of $30.00.
The stock's 52-week range extends from a low of $3.42 to a high of $30.00.
URGN News
We feel now is a pretty good time to analyse UroGen Pharma Ltd.'s ( ) business as it appears the company may be on the cusp of a considerable accomplishment. Ur...
